These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Four-year follow-up of thyrotoxic patients treated with antithyroid drugs bases on thyroid suppressibility-Prognostic value of the 20-min 131-I thyroid uptake (author's transl)]. Leclere J; Ueda M; Hartemann P; Maureira JJ; Mizrahi R; Zannetti A; Weyland M; Vaillant D Ann Endocrinol (Paris); 1980; 41(2):95-105. PubMed ID: 6162414 [TBL] [Abstract][Full Text] [Related]
9. Iodine distribution in thyroid tissue taken from hyperthyroid patients treated with Lugol's solution or carbimazole. Etling N Rev Eur Etud Clin Biol; 1971; 16(7):662-7. PubMed ID: 4107371 [No Abstract] [Full Text] [Related]
10. Studies of the thyroid iodide "trap" in man. Alexander WD; Harden RM; Shimmins J Recent Prog Horm Res; 1969; 25():423-46. PubMed ID: 4187243 [No Abstract] [Full Text] [Related]
11. Assessment of thyroid function during and after treatment of thyrotoxicosis. McLarty DG; Alexander WD J Clin Pathol; 1975 Mar; 28(3):251-4. PubMed ID: 47343 [No Abstract] [Full Text] [Related]
12. [Results of a 30 year use of synthetic thyroid antagonists]. Laroche C; Remy JM; Letellier P Therapie; 1974; 29(5):659-73. PubMed ID: 4142659 [No Abstract] [Full Text] [Related]
13. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis. Alexander WD; McLarty DG; Robertson J; Shimmins J; Brownlie BE; Harden RM; Patel AR J Clin Endocrinol Metab; 1970 Apr; 30(4):540-3. PubMed ID: 4190916 [No Abstract] [Full Text] [Related]
14. Thyroid suppressibility: follow-up for two years after antithyroid treatment. Lowry RC; Lowe D; Hadden DR; Montgomery DA; Weaver JA Br Med J; 1971 Apr; 2(5752):19-22. PubMed ID: 4101408 [TBL] [Abstract][Full Text] [Related]
15. Thyroid suppression test as index of outcome of hyperthyroidism treated with antithyroid drugs. Cassidy CE Metabolism; 1970 Oct; 19(10):745-50. PubMed ID: 4096944 [No Abstract] [Full Text] [Related]
16. [Effect of antithyroid medication on the effective half-life and uptake of 131-iodine following radioiodine therapy]. Moka D; Voth E; Schicha H Nuklearmedizin; 1997 Apr; 36(3):87-92. PubMed ID: 9162907 [TBL] [Abstract][Full Text] [Related]
17. [Thyroid gland autoantibodies in hyperthyroidism. Observations on the course of the diseases during antithyroid therapy]. Krüskemper HL; Beisenherz W; Gillich KH Schweiz Med Wochenschr; 1970 Feb; 100(8):376-80. PubMed ID: 4111093 [No Abstract] [Full Text] [Related]
18. Drug treatment in thyroid disease. Mills LC Semin Drug Treat; 1974; 3(4):377-402. PubMed ID: 4132535 [No Abstract] [Full Text] [Related]
19. [Reduced antithyroid agents as a result of radioiodine therapy?]. Sabri O; Büll U Nuklearmedizin; 1999; 38(4):3-6. PubMed ID: 10392372 [No Abstract] [Full Text] [Related]
20. [T-lymphocytes, the TRH-test and the suppression test in thyreostatically treated hyperthyroidism]. Hackenberg K; Cohnen G; Wiermann H; Reinwein D; von zum Mühlen A Verh Dtsch Ges Inn Med; 1975; 81():1555-8. PubMed ID: 58495 [No Abstract] [Full Text] [Related] [Next] [New Search]